Plasma annexin A5 level relates inversely to the severity of coronary stenosis

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 674-680

  van Tits, Lambertus J H ^a   van Heerde, Waander L ^a   van der Vleuten, Gerly M ^a   de Graaf, Jacqueline ^a   Grobbee, Diederick E ^b   van de Vijver, Lucy P L ^c   Stalenhoef, Anton F ^a   Princen, Hans M ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LOUIS BOLK INSTITUTE   (Netherlands)

^d TNO   (Netherlands)

Author keywords

Angiography; Annexin A5; Atherosclerosis; Cardiovascular diseases; Coronary disease; Coronary stenosis; Oxidized low density lipoprotein; Oxidized phospholipids

Indexed keywords

BIOLOGICAL MARKER; LIPOCORTIN 5; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANNEXIN A5; C-REACTIVE PROTEIN; CAROTID ARTERIES; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

EID: 34047164153     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.020     Document Type: Article

References (36)

1. van Heerde L., Lap P., Schoormans S., de Groot P.G., Reutelingsperger C., and Vroom T. Localization of annexin A5 in human tissues. Annexins 1 (2004) e56-e62
2. Kaneko N., Matsuda R., Hosoda S., Kajita T., and Ohta Y. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin. Chim. Acta 251 (1996) 65-80
3. Peetz D., Hafner G., Blankenberg S., Peivandi A.A., Schweigert R., Brunner K., Dahm M., Rupprecht H.J., and Mockel M. Annexin V does not represent a diagnostic alternative to myoglobin for early detection of myocardial infarction. Clin. Lab. 48 (2002) 517-523
4. Andree H.A., Stuart M.C., Hermens W.T., Reutelingsperger C.P., Hemker H.C., Frederik P.M., and Willems G.M. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J. Biol. Chem. 267 (1992) 17907-17912
5. van Tits L.J., de Graaf J., Toenhake H., van Heerde W., and Stalenhoef A. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 717-722
6. Nishi K., Itabe H., Uno M., Kitazato K.T., Horiguchi H., Shinno K., and Nagahiro S. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1649-1654
7. van Tits L.J., van Himbergen T.M., Lemmers H.L., de Graaf J., and Stalenhoef A.F. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 185 (2006) 307-312
8. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., and Becker A.E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
9. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., and van de werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 844-848
10. Holvoet P., Harris T.B., Tracy R.P., Verhamme P., Newman A.B., Rubin S.M., Simonsick E.M., Colbert L.H., and Kritchevsky S.B. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1444-1448
11. Hulthe J., and Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1162-1167
12. Toshima S., Hasegawa A., Kurabayashi M., Itabe H., Takano T., Sugano J., Shimamura K., Kimura J., Michishita I., Suzuki T., and Nagai R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2243-2247
13. Cederholm A., Svenungsson E., Jensen-Urstad K., Trollmo C., Ulfgren A.K., Swedenborg J., Fei G.Z., and Frostegard J. Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 198-203
14. Isobe S., Tsimikas S., Zhou J., Fujimoto S., Sarai M., Branks M.J., Fujimoto A., Hofstra L., Reutelingsperger C.P., Murohara T., Virmani R., Kolodgie F.D., Narula N., Petrov A., and Narula J. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J. Nucl. Med. 47 (2006) 1497-1505
15. Kolodgie F.D., Petrov A., Virmani R., Narula N., Verjans J.W., Weber D.K., Hartung D., Steinmetz N., Vanderheyden J.L., Vannan M.A., Gold H.K., Reutelingsperger C.P., Hofstra L., and Narula J. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 (2003) 3134-3139
16. Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A., Daemen M.J., Mess W.H., Hofstra L., and Narula J. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N. Engl. J. Med. 350 (2004) 1472-1473
17. Gonzalez-Conejero R., Corral J., Roldan V., Martinez C., Marin F., Rivera J., Iniesta J.A., Lozano M.L., Marco P., and Vicente V. A common polymorphism in the annexin V Kozak sequence (-1C > T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Blood 100 (2002) 2081-2086
18. van de Vijver L.P., Kardinaal A.F., van Duyvenvoorde W., Kruijssen D.A., Grobbee D.E., van Poppel G., and Princen H.M. LDL oxidation and extent of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 193-199
19. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7 (1991) 403-422
20. Demacker P.N., Hessels M., Toenhake-Dijkstra H., and Baadenhuijsen H. Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio. Clin. Chem. 43 (1997) 663-668
21. Lopes-Virella M.F., Virella G., Evans G., Malenkos S.B., and Colwell J.A. Immunonephelometric assay of human apolipoprotein. AI Clin. Chem. 26 (1980) 1205-1208
22. Demacker P.N., Bolat E., Toenhake-Dijkstra H.I., and van Tits L.J. Factors influencing isoprotein dependency of polyclonal apolipoprotein(a) assays. Clin. Chem. 50 (2004) 2161-2163
23. van Tits L.J., de Graaf J., Hak-Lemmers H., Bredie S., Demacker P., Holvoet P., and Stalenhoef A. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab. Invest. 83 (2003) 13-21
24. Holvoet P., Macy E., Landeloos M., Jones D., Nancy J.S., van de Werf F., and Tracy R.P. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 52 (2006) 760-764
25. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
26. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., and Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24 (1994) 1468-1474
27. Reddy K.G., Nair R.N., Sheehan H.M., and Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23 (1994) 833-843
28. Holvoet P., Kritchevsky S.B., Tracy R.P., Mertens A., Rubin S.M., Butler J., Goodpaster B., and Harris T.B. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53 (2004) 1068-1073
29. Meisinger C., Baumert J., Khuseyinova N., Loewel H., and Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112 (2005) 651-657
30. Nordin F.G., Hedblad B., Berglund G., and Nilsson J. Plasma oxidized LDL: a predictor for acute myocardial infarction?. J. Intern. Med. 253 (2003) 425-429
31. Shimada K., Mokuno H., Matsunaga E., Miyazaki T., Sumiyoshi K., Miyauchi K., and Daida H. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 174 (2004) 343-347
32. Halcox J.P., Schenke W.H., Zalos G., Mincemoyer R., Prasad A., Waclawiw M.A., Nour K.R., and Quyyumi A.A. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
33. Neunteufl T., Heher S., Katzenschlager R., Wolfl G., Kostner K., Maurer G., and Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am. J. Cardiol. 86 (2000) 207-210
34. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
35. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
36. Naruko T., Ueda M., Ehara S., Itoh A., Haze K., Shirai N., Ikura Y., Ohsawa M., Itabe H., Kobayashi Y., Yamagishi H., Yoshiyama M., Yoshikawa J., and Becker E.A. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 877-883